AI assistant
ELI LILLY & Co — Director's Dealing 2024
Jan 10, 2024
29745_dirs_2024-01-10_8df32eb1-b1c4-4fb4-bfdc-60b2d8f78ae7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2024-01-09
Reporting Person: LILLY ENDOWMENT INC (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-01-09 | Common Stock | S | 10873 | $630.389 | Disposed | 99743549 | Direct |
| 2024-01-09 | Common Stock | S | 5608 | $631.715 | Disposed | 99737941 | Direct |
| 2024-01-09 | Common Stock | S | 14566 | $632.521 | Disposed | 99723375 | Direct |
| 2024-01-09 | Common Stock | S | 3491 | $633.410 | Disposed | 99719884 | Direct |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $630.00 to $630.97, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), and (4) to this Form 4.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $631.155 to $632.15, inclusive.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $632.18 to $633.125, inclusive.
F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $633.20 to $633.745, inclusive.